Opko Health Inc (OPK) - News Archive

Showing 7 of 7 results.

OPKO Health and Entera Bio Forge Pioneering Alliance to Launch Oral Dual Agonist Tablet, Anticipating Strategic Growth and Shareholder Value

MIAMI and JERUSALEM March 17, 2025 In a significant leap forward for biotechnology and pharmaceutical innovation, OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) have announced a pivotal collaboration...

Mar 17, 2025 • Major Pharmaceutical Preparations Industry Shares

ModeX Therapeutics Secures $35 Million BARDA Funding Amid OPKO Healthns Efforts to Reinvent Share Value Amid Financial Losses,

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program: A Strategic Move Amidst OPKO Healthns Financial ChallengesIn a significant...

Oct 7, 2024 • Major Pharmaceutical Preparations Industry Financing Agreement

OPKO Health, Inc. Initiates $100 Million Share Repurchase Program to Boost Shareholder Value

OPKO Health, Inc. Announces $100 Million Share Repurchase ProgramMIAMI, July 18, 2024 - OPKO Health, Inc. (NASDAQ: OPK), a leading healthcare company, has recently made an exciting announcement. The company s Board of D...

Jul 18, 2024 • Major Pharmaceutical Preparations Industry Shares

OPKO Health Secures $250 Million Note Purchase Agreement with HealthCare Royalty, Boosting Financial Stability

In a major financial move, OPKO Health, Inc. has announced a groundbreaking $250 million non-dilutive note purchase agreement with HealthCare Royalty, secured by OPKO s profit share payments from Pfizer for NGENLA. NGEN...

Jul 17, 2024 • Major Pharmaceutical Preparations Industry Financing Agreement

Potential Breakthrough in HIV Treatment: ModeX Trispecific Antibody Shows Promising Safety and Efficacy Results in Phase 1 Study

is pleased to present an article summarizing the recent findings from an AIDS Clinical Trial Group s Phase 1 study on ModeX Trispecific Antibody, a potential game-changer in the treatment and prevention of HIV. This sig...

Mar 5, 2024 • Major Pharmaceutical Preparations Industry Product Service News

OPKO Health Shows Strategic Finesse with $200 Million Offering as Repurchase Program Steers Shareholder Value and Financial Strength

OPKO Health Announces Strategic Allocation of Proceeds from Private Offering and Launches Ambitious Stock and Note Repurchase ProgramOPKO Health, a leading healthcare company, has recently declared the pricing of its pr...

Jan 5, 2024 Financing Agreement

OPKO Health Empowers Financial Reinforcement with Private Offering of Convertible Senior Notes: Unveiling a Blueprint for Success

Proceeds to Be Utilized for Repurchasing Common Stock and the Convertible Senior Notes: OPKO Health s Latest Move in Ensuring Financial StabilityOPKO Health, a leading healthcare company committed to developing innovati...

Jan 3, 2024 Financing Agreement